Music Effect on Concentration and Gait in Cerebral Palsy Children During Physical Therapy Sessions (NMT\CP)

June 3, 2026 updated by: Shrouk Mohamed Mahmoud Hussein, Cairo University

Effect of Physiotherapy With Auditory Cueing on Concentration and Gait in Children With Spastic Cerebral Palsy

  • To investigate the effect of music therapy as an additional intervention with physical therapy on concentration in children with spastic CP.
  • To investigate the effect of music therapy as an additional intervention with physical therapy on gait parameters for the children with spastic CP.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Physical therapy only could be not attractive for child if it done by the traditional way; focus on motor part and no need to involve the sensory part through the rehabilitation.

Sense of hearing could be a unique one to stimulate for a better child attention during physical therapy session, even child with blindness could benefit from this idea.

Using music for attracting attention of the child as a therapeutic way so the child can walk properly regarding time and pace.

Singing as a live form of music could be more sensitive and interactive for child-therapist bond which is important to include the child as an active participant as child is being rehabilitated not just treatment.

Rehabilitation means to involve the child as a whole at this complicated process, not to move a passive limb.

Rehabilitation of CP:

  • A "temporal axis": Habilitation/rehabilitation should begin early and continuously - a minimum within the first years of child's life - and intensively - individually designed to meet child's needs.
  • A "spatial axis": where individual space, family, school, and social affair places must be all considered.
  • An "individual axis": Rehabilitation must observe the child as an active participant, not as a passive person of whom needs care.
  • A "relational axis": the standard of taking into consideration the relationship of the child and people who take care of him/her in different contexts of their life (Trabacca et al., 2016).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
40

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.
  • Name: Shrouk Mahmoud Mohamed researcher at Cairo university faculty of physical therapy, master
  • Phone Number: +201002952353
  • Email: shrouk.rere@gmail.com

Study Contact Backup

Study Locations

  • Egypt
    • Giza Governorate
      • Dokki, Giza Governorate, Egypt, 02
        • Faculty of Physical Therapy Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • The children age ranged from 5 to 7 years old (early childhood).

    • Spasticity degree ranges from 1 to 1+ as measured by the Modified Ashworth Scale
    • Children with lack of concentration according to MARS (Moss Attention Rating Scale)
    • Children can stand alone and walk.

Exclusion Criteria:

  • • Children with deafness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: MT and PT
music and physical therapy
Behavioral: Music therapy
Neurologic music therapy (NMT) Listening to music and moving rhythmically.
Other: physical therapy traditional
program for gait improvement ( Standing, balance and gait training)
Active Comparator: PT
Physical therapy
Other: physical therapy traditional
program for gait improvement ( Standing, balance and gait training)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
concentration as a cognitive function
Time Frame: pre intervention and 3 months post intervention
ability of child to pay attention during physical therapy sessions and be interactive with the therapist, measured by Moss Attention Rating Scale, score of 22 (minimum score) to less than 110 (maximum score), Higher scores indicate better attention.
pre intervention and 3 months post intervention
Gait
Time Frame: pre intervention and 3 months post intervention
improvement measured by Gross motor function measure 88 (gait section), 0 (minimum score) to 100 (maximum score) percentage %
pre intervention and 3 months post intervention
Kinovea, (Spatial and Temporal Parameters)
Time Frame: pre and 3 months post intervention
Kinovea, (Spatial and Temporal Parameters); Step length in centimeters (higher score better)
pre and 3 months post intervention
Kinovea, (Spatial and Temporal Parameters) ; stride length in centimeters (higher score better)
Time Frame: pre and 3 months post intervention
Kinovea, (Spatial and Temporal Parameters); stride length in centimeters (higher score better)
pre and 3 months post intervention
Gait (cadence)
Time Frame: pre and 3 months post intervention
Using Kinovea, cadence measured in steps\minute (lower score better).
pre and 3 months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cairo University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
physical therapy of cairo university

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Kamal El-sayed Shoukry, Doctorate, Professor of Physical Therapy for Pediatrics Faculty of Physical Therapy Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 20, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 15, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 15, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 13, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 3, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 4, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 4, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 3, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • P.T.REC/012/002297

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings